Nuwellis (NUWE) Change in Accured Expenses (2011 - 2026)
Nuwellis (NUWE) posted Change in Accured Expenses of $398000.0 for Q1 2026, up 178.97% on a QoQ basis from -$504000.0 in Q4 2025, and up 186.33% year-over-year from $139000.0 in Q1 2025.
Nuwellis (NUWE) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Nuwellis' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $398000.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 186.33% year-over-year to $398000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $665000.0 (up 140.62% YoY) and the FY2025 annual result came in at $406000.0, up 164.86% from the prior year.
- Change in Accured Expenses was $398000.0 for Q1 2026 at Nuwellis, up from -$504000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.2 million in Q1 2024 and bottomed at -$1.3 million in Q3 2024.
- A 5-year average of -$2588.2 and a median of $54000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses slumped 1155.56% — and 2025, when it soared 457.94%.
- Nuwellis' Change in Accured Expenses stood at $1.0 million in 2022, then tumbled by 82.62% to $178000.0 in 2023, then plunged by 178.65% to -$140000.0 in 2024, then plunged by 260.0% to -$504000.0 in 2025, then soared by 178.97% to $398000.0 in 2026.
- Business Quant data shows NUWE's Change in Accured Expenses at $398000.0 in Q1 2026, -$504000.0 in Q4 2025, and -$378000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 398,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 398,000.00 |
| Mar 31, 2026 | 398,000.00 |
| Dec 31, 2025 | -504,000.00 |
| Dec 31, 2025 | -504,000.00 |
| Sep 30, 2025 | -378,000.00 |
| Sep 30, 2025 | -378,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | -140,000.00 |
| Dec 31, 2024 | -140,000.00 |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | -321,000.00 |
| Jun 30, 2024 | -321,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 178,000.00 |
| Dec 31, 2023 | 178,000.00 |